A Case of Aplastic Anemia Associated with Ticlopidine / 대한뇌혈관학회지
Korean Journal of Cerebrovascular Disease
;
: 81-82, 2001.
Article
Dans Coréen
| WPRIM
| ID: wpr-185314
ABSTRACT
Aplastic anemia is a rare side-effect associated with ticlopidine therapy. We report one case of severe aplastic anemia developed after the use of ticlopidine. A 72-year-old woman took ticlopidine at 500 mg/day to prevent a secondary stroke. Forty days after starting ticlopidine, she developed general weakness and nausea. She showed pancytopenia and was diagnosed as aplastic anemia, confirmed by bone marrow examination. Twelve days after the withdrwal of ticlopidine, the hematologic parameters improved. Physicians are reminded that complete blood cell counts and white blood cell count differentials should be monitored every 2 weeks in ticlopidine users during the first 3 months of treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pancytopénie
/
Hémogramme
/
Myélogramme
/
Ticlopidine
/
Accident vasculaire cérébral
/
Anémie aplasique
/
Numération des leucocytes
/
Nausée
Limites du sujet:
Adulte très âgé
/
Femelle
/
Humains
langue:
Coréen
Texte intégral:
Korean Journal of Cerebrovascular Disease
Année:
2001
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS